#ACTRIMS2020 – CNM-Au8 a Potential ‘Breakthrough’ in MS Therapy, Clene CMO Says
#ACTRIMS2020 – CNM-Au8 a Potential ‘Breakthrough’ in MS Therapy, Clene CMO Says
CNM-Au8
Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis (REPAIR-MS)
https://clinicaltrials.gov/ct2/show/NCT03993171?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14
Condition : Relapsing Remitting Multiple Sclerosis
Intervention : Drug: gold nanocrystals
Sponsors : Clene Nanomedicine; University of Texas Southwestern Medical Center
Not yet recruiting
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis (REPAIR-MS)
NCT03993171
Thu, 20 Jun 2019 12:00:00 EDT
First Added: 06/20/19 09:47AM
Clene Nanomedicine Awarded Research Grant from the National Multiple Sclerosis Society to Support Clinical Development of its Lead Nanocatalytic Therapeutic, CNM-Au8
https://www.prnewswire.com/news-releases/clene-nanomedicine-awarded-research-grant-from-the-national-multiple-sclerosis-society-to-support-clinical-development-of-its-lead-nanocatalytic-therapeutic-cnm-au8-300937462.html
Clene Nanomedicine Awarded Research Grant from the National Multiple Sclerosis Society to Support Clinical Development of its Lead Nanocatalytic Therapeutic, CNM-Au8
